Author:
Elhabak Mona,Osman Rihab,Mohamed Mona,El-Borady Ola M.,Awad Gehanne A. S.,Mortada Nahed
Abstract
AbstractAdvances in cancer nanotechnology aim at improving specificity and effectiveness for tumor treatment. Amalgamation of different treatment modalities is expected to provide better cancer combating. Herein, We developed a long circulating nanocarrier comprising trastuzumab (TZB) surface modified polylactic-co-glycolic acid (PLGA) nanoparticles (NPs) co-encapsulating magnolol (Mag) and gold nanoparticles (GNPs). A modified single step nanoprecipitation method was adopted ensuring particle coating with D-α-tocopheryl polyethylene glycol 1000 succinate (TPGS) while co-encapsulating GNPs. TZB was then anchored on NPs surface using a carbodiimide chemistry. The cytotoxicity of the developed system was evaluated with and without photothermal irradiation. NPs cellular uptake was then followed using confocal microscopical imaging. A hybrid matrix composed of PLGA/TPGS and surface decorated with TZB with a conjugation efficiency of ˃65%, was confirmed via FTIR, 1HNMR. GNPs could only be included in the NPs, when placed in the organic phase as evidenced by the shifted GNPs surface plasmonic resonance and confirmed via imaging coupled with energy dispersive X-ray analysis. Optimized NPs (136.1 ± 1.3 nm, −8.2 ± 1 mV and Mag encapsulation efficiency of 81.4 ± 1.8%) were able to boost Mag cytotoxicity on breast cancer cells while providing a selective multifunctional therapy with an added photothermal effect.
Publisher
Springer Science and Business Media LLC
Reference44 articles.
1. Comşa, Ş., Cîmpean, A. M. & Raica, M. The Story of MCF-7 Breast cancer cell line: 40 years of experience in research. Anticancer. Res. 35, 3147–54 (2015).
2. Mona, A. M., Abo-Elfadl, M. T. & Gamal-Eldeen, A. M. Trastuzumab augments apoptotic cell death of MCF-7 and MDA-MB-231 breast cancer cell lines. J. Pharm. Sci. Res. 11, 324–330 (2019).
3. Sanchez-Moreno, P. et al. Smart drug-delivery systems for cancer nanotherapy. Curr. Drug. Targets 19, 339–359, https://doi.org/10.2174/1389450117666160527142544 (2018).
4. Liu, D., Yang, F., Xiong, F. & Gu, N. The smart drug delivery system and its clinical potential. Theranostics 6, 1306–1323, https://doi.org/10.7150/thno.14858 (2016).
5. Liu, Y. et al. The natural compound magnolol inhibits invasion and exhibits potential in human breast cancer therapy. Sci. Rep. 3, 3098–3107, https://doi.org/10.1038/srep03098 (2013).
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献